Nextracker: "No. Nextracker's a mistake that I made." Trump Media & Technology: "That is what I call an opaque ...

Waldron Private Wealth LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the 3rd ...

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval ...

Eastern Bank increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 145.8% in the 3rd quarter, according ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Bernstein has recently initiated Eli Lilly And Co (LLY) stock to Outperform rating, as announced on October 17, 2024, according to Finviz. Earlier, on September 13, 2024, Citigroup had resumed the ...

The justices are considering an effort challenging longstanding case law blocking the state’s ability to probe inflated drug ...

Eli Lilly (LLY) is suing medical spas and online vendors who claim their products contain the main ingredients of GLP-1 weight-loss drug Zepbound, according to Reuters. Lastly, Bloomberg reports that ...